Your browser doesn't support javascript.
loading
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease.
Pierson, Sheila K; Shenoy, Sushila; Oromendia, Ana B; Gorzewski, Alexander M; Langan Pai, Ruth-Anne; Nabel, Christopher Shield; Ruth, Jason R; Parente, Sophia A T; Arenas, Daniel J; Guilfoyle, Mary; Reddy, Manjula; Weinblatt, Michael; Shadick, Nancy; Bower, Mark; Pria, Alessia Dalla; Masaki, Yasufumi; Katz, Laura; Mezey, Jason; Beineke, Philip; Lee, David; Tendler, Craig; Kambayashi, Taku; Fosså, Alexander; van Rhee, Frits; Fajgenbaum, David C.
Afiliação
  • Pierson SK; Center for Cytokine Storm Treatment & Laboratory, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Shenoy S; Castleman Disease Collaborative Network, Philadelphia, PA.
  • Oromendia AB; Medidata Solutions, New York, NY.
  • Gorzewski AM; Medidata Solutions, New York, NY.
  • Langan Pai RA; Center for Cytokine Storm Treatment & Laboratory, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Nabel CS; Castleman Disease Collaborative Network, Philadelphia, PA.
  • Ruth JR; Center for Cytokine Storm Treatment & Laboratory, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Parente SAT; Castleman Disease Collaborative Network, Philadelphia, PA.
  • Arenas DJ; Castleman Disease Collaborative Network, Philadelphia, PA.
  • Guilfoyle M; Center for Cytokine Storm Treatment & Laboratory, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Reddy M; Castleman Disease Collaborative Network, Philadelphia, PA.
  • Weinblatt M; Center for Cytokine Storm Treatment & Laboratory, Department of Medicine, University of Pennsylvania, Philadelphia, PA.
  • Shadick N; Castleman Disease Collaborative Network, Philadelphia, PA.
  • Bower M; Janssen Pharmaceuticals, Raritan, NJ.
  • Pria AD; Janssen Pharmaceuticals, Raritan, NJ.
  • Masaki Y; Department of Medicine, Brigham and Women's Hospital, Boston, MA.
  • Katz L; Department of Medicine, Brigham and Women's Hospital, Boston, MA.
  • Mezey J; Department of Medicine, Chelsea & Westminster Hospital, London, United Kingdom.
  • Beineke P; Department of Medicine, Chelsea & Westminster Hospital, London, United Kingdom.
  • Lee D; Department of Hematology and Immunology, Kanazawa Medical University, Ishikawa, Japan.
  • Tendler C; Medidata Solutions, New York, NY.
  • Kambayashi T; Department of Genetic Medicine, Weill Cornell Medicine, New York, NY.
  • Fosså A; Medidata Solutions, New York, NY.
  • van Rhee F; Medidata Solutions, New York, NY.
  • Fajgenbaum DC; Janssen Pharmaceuticals, Raritan, NJ.
Blood Adv ; 5(17): 3445-3456, 2021 09 14.
Article em En | MEDLINE | ID: mdl-34438448
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia do Linfonodo Gigante / Herpesvirus Humano 8 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Panamá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia do Linfonodo Gigante / Herpesvirus Humano 8 Tipo de estudo: Prognostic_studies Limite: Humans País/Região como assunto: America do norte Idioma: En Revista: Blood Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Panamá